Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Atomic AI does not list a price
Free plan
Tie
Neither has one
Higher rating
Immunai
3.6 against 4.0
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Atomic AI
Immunai
Our rating
3.6
4.0Better
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
Proprietary ATOM-1 foundation model for RNA structure/function prediction
Integrated wet-lab assay validation cycle
Focus on both small-molecule and RNA-based drug candidates
Peer-reviewed research published in Science Magazine
Purpose-built for RNA-centric medicine discovery
AMICA-OS platform built on single-cell multi-omic immune system data
Target discovery tools for identifying new drug candidates from immune cell behavior
Preclinical evaluation modeling for testing target hypotheses before trials
Clinical trial optimization using immune-response data
One of the industry's largest clinical immunology datasets, built through 30-plus pharma partnerships
Pros
Named, real proprietary model with peer-reviewed validation
Combines computational prediction with physical lab experiments, not AI in isolation
Addresses a genuinely hard problem (RNA structure prediction) with real scientific rigor
Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
Covers the full pipeline from target discovery through clinical trial optimization rather than one narrow step
Named partnerships with AstraZeneca, Boehringer Ingelheim, Pfizer, and Novo Nordisk demonstrate real commercial traction
Cons
Not a self-serve product - a research/drug-development platform for pharma partners
Pricing and access model aren't publicly detailed
Outcomes depend on the long, uncertain timelines inherent to drug development
No published pricing; every engagement is a custom partnership negotiation
Built exclusively for pharmaceutical R&D, inaccessible to academic labs or individual researchers without a deal
Value depends on data-sharing arrangements with partners, which take time to negotiate and set up
Company
Atomic AI
Immunai, founded 2018
Prices come from each vendor's pricing page, last checked 20260826. Check the vendor before you buy.
FAQ
Questions people ask
Is Atomic AI better than Immunai?
In our reviews Atomic AI scores 3.6 and Immunai scores 4.0. The better pick depends on the job. Atomic AI: ATOM-1, a proprietary foundation model, predicts RNA structure and function more precisely than any prior approach - fused with real wet-lab assays to accelerate RNA-targeted drug discovery, published in Science. Immunai: AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners.
Immunai
Atomic AI
